Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Relapsed or Refractory Acute Myeloid Leukemia. Show all posts
Showing posts with label Relapsed or Refractory Acute Myeloid Leukemia. Show all posts
Friday, January 20, 2023

FDA Approves Rezlidhia (olutasidenib) for Relapsed or Refractory Acute Myeloid Leukemia with a Susceptible IDH1 Mutation

›
Rigel Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA)  approval  of  Rezlidhia (olutasidenib) capsules for the t...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.